Oncology
16 drugs are in development for Advanced Solid Tumors.
- Companies
- 14
- Clinical trials
- 95
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Advanced Solid Tumors pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(4)
Phase 2(3)
| Drug | Company |
|---|---|
| agen2373 | AGENUS INC (AGEN) |
| solnerstotug | Faeth Therapeutics, Inc. (FTH) |
| TYRA-430 | Tyra Biosciences, Inc. (TYRA) |
Phase 1(5)
Phase 1/Phase 2(2)
| Drug | Company |
|---|---|
| iov-5001 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) |
| XmAb662 | Xencor Inc (XNCR) |
Phase 2/Phase 3(2)
| Drug | Company |
|---|---|
| eik1004 | Eikon Therapeutics Inc. (EIKN) |
| eik1005 | Eikon Therapeutics Inc. (EIKN) |
About this indication
Advanced Solid Tumors context
Oncology·MeSH: Neoplasms (D009369)
Narrower concept of MeSH descriptor Neoplasms
Compare drugs
Frequently asked questions
How many drugs are in development for Advanced Solid Tumors?
BioSniper tracks 16 drugs in development for Advanced Solid Tumors across 14 companies.
How many clinical trials target Advanced Solid Tumors?
There are 95 clinical trials targeting Advanced Solid Tumors tracked by BioSniper.